Cargando…
1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
BACKGROUND: In-vitro studies have shown synergistic bactericidal activity with daptomycin (DAP) plus β-lactam antimicrobials against vancomycin resistant enterococci (VRE). There is a paucity of data regarding clinical outcomes with this combination in VRE bloodstream infections (BSI). The purpose o...
Autores principales: | Irusta, Nerea, Vega, Ana, Natori, Yoichiro, Abbo, Lilian M, DeRonde, Kailynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778310/ http://dx.doi.org/10.1093/ofid/ofaa439.1791 |
Ejemplares similares
-
110. Impact of Diagnostic and Antimicrobial Stewardship on Time-to-Appropriate Therapy and Clinical Outcomes in Multi-Drug Resistant Pseudomonas Infections
por: McCrink, Katie A, et al.
Publicado: (2020) -
1304. Pharmacist Impact on HIV Management in a Psychiatric Patient Population
por: Margulis, Alice, et al.
Publicado: (2019) -
Predictors of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Ontario, Canada
por: Johnstone, Jennie, et al.
Publicado: (2017) -
1250. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess
por: Al-Heeti, Omar, et al.
Publicado: (2021) -
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)